登录 | 注册    关注公众号  
微信公众号
搜索
 >  Kits>IL-8 >CEA-C004

ClinMax™ Human IL-8 ELISA Kit, PRO

For research use only.

产品概述(Product Details)

ClinMax™ Human IL-8 ELISA Kit, PRO is a ready-to-use immunoassay kit, specifically designed to quantitate natural and recombinant human IL-8 that is present in biological samples, such as human serum, plasma, and cell culture supernatants. Our ClinMax™ ELISA Kit provides several benefits:

  1. Standards to calibrate with NIBSC/WHO standards for comparable results.
  2. Fully validation in biologic samples for detection range, sensitivity, inter- and intra-plate CV, recovery, dilution linearity, specificity, and matrix effects to ensure reliable results according to ICH M11 guideline.
  3. High-quality antibody pairs and protein standards, along with rigorous quality control, to guarantee consistent results across different batches.
  4. Simplified and straightforward protocols and ready-to-use reagents to save assay time.

应用说明(Application)

The kit is developed for quantitative detection of natural and recombinant human IL-8 in serum, plasma and cell culture supernatants.

It is for research use only.

流程图(Workflow)

IL-8 Workflow

关键信息(Key Features)

AnalyteIL-8
Assay TypeSandwich-ELISA
ReactivityHuman
Sensitivity3.0 pg/mL
Range6.25 pg/mL-400 pg/mL
Assay Time1.75 hr
Sample TypeCell Culture Supernatants, Plasma, Serum.
Sample volume50 uL
Format96-wells plate breakable into 12 x 8 wells strips

Elevate your research experience with our Cytokine/Biomarker Detection Kits, where accuracy, reliability, and ease of use are converging to deliver exceptional results.

存储(Storage)

Keep the unopened kit stored at 2-8 °C. Avoid using the kit beyond its expiration date. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

 

典型数据-Typical Data Please refer to DS document for the assay protocol.

IL-8 TYPICAL DATA

For each experiment, each ELISA plate needs to set the standard curve. The minimum detectable concentration of CEA-C004 is less than 3.0 pg/mL.

 

验证(Validation)

稀释线性(Dilution Linearity)

Three human serum samples with high concentrations of IL-8 were diluted 1:2, 1:4, 1:8, 1:16, 1:32 with Dilution Buffer to produce samples with values within the dynamic range and then assayed. On average, 103.12% of IL-8 was detected from serum samples.

IL-8 DILUTION LINEARITY

批内差异(Intra-Assay Statistics)

Ten replicates of each of five samples containing different IL-8 concentrations were tested in one assay , Intra-Assay Precision CV<10%.

IL-8 INTRA-ASSAY STATISTICS

批间差异(Inter-Assay Statistics)

Five samples containing different concentrations of IL-8 were tested in three independent assays , Inter-Assay Precision CV<15%.

IL-8 INTER-ASSAY STATISTICS

回收率(Recovery)

Recombinant IL-8 was spiked into 5 human serum samples, and then analyzed. On average, 97.54% of IL-8 was recovered from serum samples.

IL-8 RECOVERY

Recombinant IL-8 was spiked into cell supernatant sample, and then analyzed. On average, 98.87% of IL-8 was recovered from serum samples.

IL-8 RECOVERY

干扰效应(Interference effect)

Bilirubin (simulated jaundice) concentration should be less than 20mg/dL, hemoglobin (simulated hemolysis) concentration should not be higher than 3500mg/dL, triglyceride (simulated lipemia) concentration may not be higher than 2.0g/L, Heparin concentration should be less than 40U/mL, EDTA concentration should be less than 4mg/mL, and Sodium citrate concentration may not be higher than 40mg/mL, it does not affect the detection result.

IL-8 INTERFERENCE EFFECT

 

组分(Materials Provided)

IDComponentsSize
CEA004-C01Pre-coated Anti-IL-8 Antibody Microplate1 plate
CEA004-C02IL-8 Calibrator20 μg×2
CEA004-C03Biotin-Anti-IL-8 Antibody Concentrated Solution100 μL
CEA004-C04Biotin Antibody Dilution Buffer8 mL
CEA004-C05IL-8 Streptavidin-HRP Concentrated Solution0.5 mL
CEA004-C06Streptavidin-HRP Dilution Buffer15 mL
CEA004-C0720× Washing Buffer50 mL
CEA004-C08Sample Dilution Buffer15 mL×2
CEA004-C09Substrate Solution12 mL
CEA004-C10Stop Solution6 mL

 

前沿进展

 
 
IL-8靶点信息
英文全称:Interleukin-8
中文全称:白细胞介素-8
种类:Homo sapiens
上市药物数量:1详情
临床药物数量:4详情
最高研发阶段:批准上市
查看更多信息
前沿进展
点击查看详细
相关产品
View All IL-8

消息提示

请输入您的联系方式,再点击提交!

确定